Synopsis
According to the Centre s affidavit, over 1.8 million doses of Covaxin are pending against its order for 20 million doses in March.
AFP
Bharat Biotech has supplied 28 million doses of Covaxin vaccines to the central government till June 12, against orders of 80 million till May end, according to the affidavit filed by the Centre in the Supreme Court. The Co-WIN dashboard shows that 38.2 million doses of Covaxin have been administered till date. This includes the supplies to the states and the private healthcare providers. According to the Centre s affidavit, over 1.8 million doses of Covaxin are pending against its order for 20 million doses in March. Supply against the government’s May order for a further 50 million doses had not yet begun.
People vaccinated against Covid-19 and yet hospitalised with the infection are likely to require shorter hospital stays, face significantly reduced need for intensive care unit support and run up lower hospital bills, a nationwide study of health insurance claims has suggested.
The study has found that vaccinated patients hospitalised for Covid-19 were discharged two days earlier than others, and that the fully vaccinated among them had a 66 per cent lower risk of needing ICU support. Also, the average hospital bill of the vaccinated patients was Rs 60,000 lower than that of unvaccinated patients.
Advertisement
“Our findings bolster the evidence for how vaccination benefits individuals,” said Prakash Subbarayan, MD of Star Health Insurance, a Chennai-based company that has handled over 300,000 Covid-related claims over the past year.
Delhi government introduced price caps on Covid-19 care at private hospitals, but failed to enforce them. This put the city’s residents, already struggling with trauma and loss, under tremendous financial strain.
Bharat Biotech promised shot cheaper than bottled water But Covaxin is 3rd costliest in world msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
As India's daily COVID-19 tallies fall, the vaccination race is on to head off another deadly wave. The government is rationing doses and the CEO of its biggest vaccine manufacturer has fled.